Downregulation of KRAB zinc finger proteins in 5-fluorouracil resistant colorectal cancer cells

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes

(2020) Sabrina Blondy et al.   CANCER SCIENCE

RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

(2019) Enrico Mini et al.   INTERNATIONAL JOURNAL OF CANCER

Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure

(2019) Maria Giovanna Francipane et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)

(2019) Uku Raudvere et al.   NUCLEIC ACIDS RESEARCH

The interactome of KRAB zinc finger proteins reveals the evolutionary history of their functional diversification

(2019) Pierre‐Yves Helleboid et al.   EMBO JOURNAL

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

(2018) Anaïs Chauvin et al.   Clinical Proteomics

The PRIDE database and related tools and resources in 2019: improving support for quantification data

(2018) Yasset Perez-Riverol et al.   NUCLEIC ACIDS RESEARCH

Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity

(2017) Jing Wang et al.   GASTROENTEROLOGY

Senescent tumor cells lead the collective invasion in thyroid cancer

(2017) Young Hwa Kim et al.   Nature Communications

TRIM28 and Interacting KRAB-ZNFs Control Self-Renewal of Human Pluripotent Stem Cells through Epigenetic Repression of Pro-differentiation Genes

(2017) Urszula Oleksiewicz et al.   Stem Cell Reports

The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging

(2016) Kanad Ghosh et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Near-optimal probabilistic RNA-seq quantification

(2016) Nicolas L Bray et al.   NATURE BIOTECHNOLOGY

The Perseus computational platform for comprehensive analysis of (prote)omics data

(2016) Stefka Tyanova et al.   NATURE METHODS

Subcellular proteomics analysis of different stages of colorectal cancer cell lines

(2016) Alex-Ane Mathieu et al.   PROTEOMICS

GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR

(2016) H Zhou et al.   Cell Death & Disease

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment

(2016) Carolina Negrei et al.   Frontiers in Pharmacology

Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer

(2015) Yu-Hsuan Chen et al.   CANCER LETTERS

Stromal contribution to the colorectal cancer transcriptome

(2015) Claudio Isella et al.   NATURE GENETICS

The consensus molecular subtypes of colorectal cancer

(2015) Justin Guinney et al.   NATURE MEDICINE

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer

(2015) Ji-Young Ahn et al.   Oncotarget

5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits

(2015) Corti Denise et al.   Oncotarget

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

(2014) Maria Giulia Cangi et al.   ANNALS OF THE RHEUMATIC DISEASES

Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines

(2014) Anne Benard et al.   APOPTOSIS

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

Proteogenomic characterization of human colon and rectal cancer

(2014) Bing Zhang et al.   NATURE

Drug Resistance in Cancer: An Overview

(2014) Genevieve Housman et al.   Cancers

Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity

(2013) Miguel A. de la Cruz-Morcillo et al.   CANCER LETTERS

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition

(2013) Paul Roepman et al.   INTERNATIONAL JOURNAL OF CANCER

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

(2013) Eva Budinska et al.   JOURNAL OF PATHOLOGY

The Effects of 5-Fluorouracil on the Proteome of Colon Cancer Cells

(2013) Consuelo Marin-Vicente et al.   JOURNAL OF PROTEOME RESEARCH

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

(2013) Felipe De Sousa E Melo et al.   NATURE MEDICINE

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

(2013) Anguraj Sadanandam et al.   NATURE MEDICINE

New Insights into the RNA-Based Mechanism of Action of the Anticancer Drug 5′-Fluorouracil in Eukaryotic Cells

(2013) Laura Mojardín et al.   PLoS One

Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

(2013) Laetitia Marisa et al.   PLOS MEDICINE

Epigenetic and genetic features of 24 colon cancer cell lines

(2013) D Ahmed et al.   Oncogenesis

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies

(2011) Francesco Crea et al.   DRUG RESISTANCE UPDATES

p53 inhibits mRNA 3′ processing through its interaction with the CstF/BARD1 complex

(2011) F I Nazeer et al.   ONCOGENE

5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency

(2010) K Bracht et al.   BRITISH JOURNAL OF CANCER

Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels

(2010) Kaspar Burger et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

(2010) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer

(2010) Sara M. Johnson et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Microsatellite instability in colorectal cancer—the stable evidence

(2010) Eduardo Vilar et al.   Nature Reviews Clinical Oncology

The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage

(2009) J-H Lee et al.   ONCOGENE

Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7

(2008) Narendra Wajapeyee et al.   CELL

Participation of DNA repair in the response to 5-fluorouracil

(2008) M. D. Wyatt et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

RNA-Based 5-Fluorouracil Toxicity Requires the Pseudouridylation Activity of Cbf5p

(2008) J. Hoskins et al.   GENETICS

Examining the link between chromosomal instability and aneuploidy in human cells

(2008) Sarah L. Thompson et al.   JOURNAL OF CELL BIOLOGY

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY

STRING 8--a global view on proteins and their functional interactions in 630 organisms

(2008) L. J. Jensen et al.   NUCLEIC ACIDS RESEARCH

Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast

(2008) M. Gustavsson et al.   RNA